BEL Pharmaceuticals & Biotechnology Net Return (BEPB)

Add to/Remove from a Portfolio  
1,918.78 -4.53    -0.24%
10:14:00 GMT - Delayed Data. Currency in EUR ( Disclaimer )
Type: Index
Market: Belgium
# Components: 8

  • Volume: -
  • Open: 1,925.48
  • Day's Range: 1,914.57 - 1,936.43
Start Trading
your capital is at risk
Pharmaceuticals & Biotechnology NR 1,918.78 -4.53 -0.24%
Add to/Remove from a Portfolio  
Start Trading
your capital is at risk

Pharmaceuticals & Biotechnology NR Overview

Prev. Close1,923.31
Day's Range1,914.57 - 1,936.43
Average Vol. (3m)-
52 wk Range1630.66 - 2147.05
1-Year Return7.19%

BEL Pharmaceuticals & Biotechnology Net Return News & Analysis

Related Articles

Most Active Stocks

  Name Last Prev. High Low Chg. % Vol. Time
Tigenix NV 0.9470 0.8790 0.9650 0.8630 +7.74% 1.41M 10:09:00  
Galapagos 38.465 38.430 40.500 38.000 +0.09% 162.80K 10:13:00  
Mdxhealth 3.799 3.680 3.799 3.680 +3.23% 61.02K 10:10:00  
UCB 67.92 68.14 68.54 67.68 -0.32% 54.40K 10:12:00  
Ablynx NV 11.100 11.125 11.295 11.100 -0.22% 30.64K 10:14:00  
Celyad 33.42 33.42 33.88 33.00 -1.09% 10.68K 10:10:00  
Tubize-Fin 56.760 57.300 57.600 56.580 -0.94% 2.27K 09:59:00  
Thrombogenics 4.168 4.127 4.179 4.130 +0.99% 2.03K 09:40:00  

Top Gainers

Name Last Chg. Chg. %
Tigenix NV 0.9470 +0.0680 +7.74%
Mdxhealth 3.799 +0.119 +3.23%
Thrombogenics 4.168 +0.041 +0.99%
Galapagos 38.465 +0.035 +0.09%
Ablynx NV 11.100 -0.025 -0.22%

Top Losers

Name Last Chg. Chg. %
Celyad 33.42 -0.36 -1.09%
Tubize-Fin 56.760 -0.540 -0.94%
UCB 67.92 -0.22 -0.32%
Ablynx NV 11.100 -0.025 -0.22%
Galapagos 38.465 +0.035 +0.09%
Powered By

Follow Top Signal Providers

Account Nickname Net Profit P/L % Win % Weeks
SignalKING $36,341.44 449.05% 46.91% 256 Follow
SignalMAX $46,385.80 320.58% 69.23% 109 Follow
SignalWave $4,662.44 308.69% 93.33% 52 Follow
SignalPower $8,277.19 295.78% 71.89% 49 Follow
SignalGlory $17,784.73 222.31% 64.85% 87 Follow

My Sentiments

Add your sentiment:
Members' Sentiments:

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Add Chart to Comment
BEL Pharmaceuticals & Biotechnology
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Post 1000
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Post 1000
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data .

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.